The choosing of method for treatment of severe aortic stenosis in senile patients
Full text
Abstract
Introduction.Aortic valve stenosis is the most common valvular pathology in cardiac surgery patients: aortic valve stenosis correction surgery accounts for 10 to 22% of open-heart surgery. 30% of senile patients with severe aortic stenosis due to severe comorbidity and high operational mortality are denied prosthetics of the aortic valve under cardiopulmonary bypass. With the appearance of endovascular correction - minimally invasive surgical treatment methodsthe problem of choosing a method of correction of severe aortic stenosis in these patients arose. Objectives. To select a method for surgical correction of severe aortic valve stenosis in senile patients, determine the place of intra-aortic valvuloplasty in treatment, and create an algorithm for treatment of senilepatients. Patients and methods. The study included 122 patients >75 years old with severe aortic stenosis, confirmed by echocardiography (aortic valve area 40 mm Hg, peak velocity (aortic valve) >4.0 m/s), undergoing treatment at Cardiovascular Surgery Dept of the BurdenkoMain Military Clinical Hospital in 2010 – 2017. Due to the high surgical risk, patients of the first group (n = 89) underwent only conservative drug therapy, patients of the second group (n = 12) underwent prosthetic aortic valve replacement under cardiopulmonary bypass, and patients of the third group (n = 8) underwent balloon aortic valvuloplasty valve, after which 7 of them entered the fourth group, patients of the fourth group (n = 20) performed Transcatheter Aortic Valve Implantation . Results. In the maximum follow-up three-year period, the mortality rate in patients of the first group was 49.5%, the severity of heart failure in most of the surviving patients was at III-IV Class(NYHA); mortality in the second group of observation was 16.6%, there was a decrease in the severity of heart failure - the transition of most patients from III - IV to II Class (NYHA); in 7 out of 8 patients of the third group, after performing aortic valve valvuloplasty, hemodynamic stabilization was noted - in 5 patients there was a decrease in the manifestations of heart failure to III Class and in 2 patients - to II Class (NYHA), all of them entered the fourth group, in which, after performing TIAK the mortality was not notedduring the three-year observation of. Conclusions. In senile patients, surgical treatment of severe aortic stenosis is the method of choice and can significantly increase the one-year and three-year survival. In the group of senile patients with high surgical risk, endovascular correction of aortic stenosis is preferred. Balloon valvuloplasty of the aortic valve can be considered as a stage in the surgical treatment of severe aortic stenosis in patients with extremely high surgical risk. The next step in this group of patients should be performed transcatheter implantation of the aortic valve. The developed algorithm of a differentiated approach to the choice of a treatment method for severe aortic stenosis in senile patients allows a 32% increase (p <0.05) in the number of cases of radical surgical care for senile patients previously considered unpromising due to the impossibility of surgical treatment.Keywords
Stenosis, Transcatheter Aortic Valve Implantation, TAVI, Balloon Aortic Valvuloplasty, BAV, Senile PatientsДля цитирования:
Крюков Е.В., Кранин Д.Л., Федоров А.Ю., Гайдуков А.В., Назаров Д.А., Замский К.С., Варочкин К.А., Корабельников Д.И. Выбор метода лечения больных старческого возраста с выраженным аортальным стенозом. Российский медико-социальный журнал. 2019;1(1):41-52. https://doi.org/10.35571/RMSJ.2019.1.004
For citation:
Kryukov E., Kranin D., Fedorov A., Gaidukov A., Nazarov D., Zamsky K., Varochkin K., Korabelnikov D. The choosing of method for treatment of severe aortic stenosis in senile patients. Russian Medical and Social Journal. 2019;1(1):41-52. (In Russian) https://doi.org/10.35571/RMSJ.2019.1.004
References
- Mathers CD, Iburg KM, Salomon JA, et al. Global patterns of healthy life expectancy in the year 2002. BMC Public Health. 2004;4(1):66. doi https://doi.org/10.1186/1471-2458-4-66
- Baumgartner H. Aortic stenosis: medical and surgical management. Heart. 2005;91(11):1483-1488. doi https://doi.org/10.1136/hrt.2004.056176
- Iung B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-1243. doi https://doi.org/10.1016/S0195-668X(03)00201-X
- Sadée AS, Becker AE, Verheul JA. The congenital bicuspid aortic valve with post-inflammatory disease-a neglected pathological diagnosis of clinical relevance. Eur Heart J. 1994;15(4):503-506. doi https://doi.org/10.1093/oxfordjournals.eurheartj.a060534
- Brennan JM, Edwards FH, Zhao Y, O’Brien SM, Douglas PS, Peterson ED. Long-Term Survival After Aortic Valve Replacement Among High-Risk Elderly Patients in the United States. Circulation. 2012;126(13):1621-1629. doi https://doi.org/10.1161/CIRCULATIONAHA.112.091371
- Walther T, Blumenstein J, van Linden A, Kempfert J. Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Heart. 2012;98(Suppl 4):iv23-iv29. doi https://doi.org/10.1136/heartjnl-2012-302399
- Paul J, Kefer J, Beeckmans M, Speybroeck N, Boland B. Inoperable severe aortic valve stenosis in geriatric patients: treatment options and mortality rates. J Geriatr Cardiol. 2018;15(11):703-707. doi https://doi.org/10.11909/j.issn.1671-5411.2018.11.001
- Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363(17):1597-1607. doi https://doi.org/10.1056/NEJMoa1008232
- Bakaeen FG, Chu D, Ratcliffe M, et al. Severe Aortic Stenosis in a Veteran Population: Treatment Considerations and Survival. Ann Thorac Surg. 2010;89(2):453-458. doi https://doi.org/10.1016/j.athoracsur.2009.10.033
- Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84(6):2383-2397. doi https://doi.org/10.1161/01.CIR.84.6.2383
- Wang A, Kevin Harrison J, Bashore TM. Balloon aortic valvuloplasty. Prog Cardiovasc Dis. 1997;40(1):27-36. doi https://doi.org/10.1016/S0033-0620(97)80020-5
- Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic Stenosis in the Elderly. J Am Coll Cardiol. 2013;62(11):1002-1012. doi https://doi.org/10.1016/j.jacc.2013.05.015
- Chitsaz S, Jaussaud N, Chau E, et al. Operative Risks and Survival in Veterans With Severe Aortic Stenosis: Surgery Versus Medical Therapy. Ann Thorac Surg. 2011;92(3):866-872. doi https://doi.org/10.1016/j.athoracsur.2011.04.028
- Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy. Circulation. 2014;130(17):1483-1492. doi https://doi.org/10.1161/CIRCULATIONAHA.114.009834
- Kryukov E, Chernetsov V, Kranin D, et al. First experience of transcatheter aortic valve implantation in medical center in Russia. Bull Pirogov Natl Med Surg Cent. 2017;12(1):21-24.
- Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardio-Thoracic Surg. 2012;42(4):S1-S44. doi https://doi.org/10.1093/ejcts/ezs455
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791. doi https://doi.org/10.1093/eurheartj/ehx391
- Mareev VY, Ageev FT, Arutyunov GP, Koroteev AV, Revishvili AS. National clinical guidelines for diagnostics and treaatment of Chronic heart failure (CHF) (3d revision). Russ Hear Fail J. 2010;11(1):3-62.
- Mareev VY, Ageev FT, Arutyunov GP, Koroteev AV, Mareev YV, Ovchinnikov AG. National clinical guidelines for diagnostics and treatment of Chronic heart failure (CHF) (4th revision). Russ Hear Fail J. 2013;14(7):379-472. (In Russ.).
- Mareev VY, Fomin IV, Ageev FT, et al. Clinical guidelines. Chronic heart failure (CHF). Russ Hear Fail J. 2017;18(1):3-40. doi https://doi.org/10.18087/rhfj.2017.1.2346
- Mareev VY, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;17(S6):1-164. doi https://doi.org/10.18087/cardio.2475
- Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thoracic Surg. 1999;16(1):9-13. doi https://doi.org/10.1016/S1010-7940(99)00134-7
- Roques F. The logistic EuroSCORE. Eur Heart J. 2003;24(9):882. doi https://doi.org/10.1016/S0195-668X(02)00799-6
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373-383. doi https://doi.org/10.1016/0021-9681(87)90171-8
- Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41(3):237-248. doi https://doi.org/10.1016/0165-1781(92)90005-N
How to Cite
License
Copyright (c) 2019 Russian Medical and Social Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




























